Pathophysiology and Disease Mechanisms

Alzheimer's illness is a dynamic dementia with loss of neurons and the nearness of two fundamental infinitesimal neuropathological trademarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, an uncommon familial shape, is caused because of change of one out of three qualities: (amyloid antecedent protein), (presenilin 2) or (presenilin 1). Sporadic shape happens more often than not after age of 65 and records for most cases; it in all likelihood comes about because of a blend of hereditary and impact of condition. Affirmed chance elements for sporadic AD are age and the nearness of the E4 allele of (Apo lipoprotein E). Amyloid plaques contain for the most part of the neurotoxic peptide amyloid (Aβ, Abeta), cut consecutively from a bigger antecedent protein (APP) by two chemicals: β-secretase (additionally called BACE1) and γ-secretase (involving four proteins, presenilin is one of them). On the off chance that APP is first separated by the chemical α-secretase as opposed to β-secretase then Aβ is not framed. Neurofibrillary tangles contain for the most part of the protein tau which ties with microtubules, which encouraging the neuronal transport framework. Tau uncoupling from microtubules and conglomeration into tangles hinders transport and results in dismantling of microtubule. Phosphorylation of tau may have an essential part in this. Specific defencelessness of neuronal frameworks, for example, the cholinergic, serotonergic, and noradrenergic and glutamatergic frameworks shape the premise of current objective pharmacological treatment.

 

  • Stem cells and Cell demise
  • Cellular flagging, kinases, phosphates, calcium
  • Cerebral Amyloid Angiopathy
  • Pathogenesis of Alzheimer’s Disease

Related Conference of Pathophysiology and Disease Mechanisms

July 20-21, 2026

37th World Congress on Neurology and Neuroscience

Amsterdam, Netherlands
July 23-24, 2026

14th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan
November 23-24, 2026

16th Global Alzheimers Summit

Paris, France
November 24-25, 2026

38th World Conference on Neurology

Rome, Italy
December 16-17, 2026

12th International Conference on Brain Injury & Neuro Surgeons

Amsterdam, Netherlands
December 21-22, 2026

6th International Conference on Child Neurology

Paris, France
December 28-29, 2026

39th European Neurology Congress

Amsterdam, Netherlands
December 28-29, 2026

18th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
March 22-23, 2027

8th International Conference on Neurologists

Singapore City, Singapore
March 24-25, 2027

38th Conference on Clinical Neuroscience and Neurogenetics

Geneva, Switzerland

Pathophysiology and Disease Mechanisms Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in